FIELD: medicine; ophthalmology.
SUBSTANCE: invention refers to treatment of recurrent pterygium. For this purpose surgical procedure is performed, and after surgery prospidinum is singly introduced dosed 30 mg subconjunctivally. Method prevents disease relapse due to cytostatic, antiproliferative and anti-inflammatory action of prospidinum not causing general and local by-effects if dosed as specified.
EFFECT: disease relapse prevention.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTION OF PTERYGIUM RELAPSE | 2007 |
|
RU2351298C1 |
| METHOD FOR SURGICAL MANAGEMENT OF RECURRENT PTERYGIUM | 2023 |
|
RU2821131C1 |
| METHOD OF SURGICAL TREATMENT OF PTERYGIUM | 2016 |
|
RU2611939C1 |
| METHOD FOR REMOVING RECURRENT PTERYGIUM | 2006 |
|
RU2308253C1 |
| METHOD OF SURGICAL TREATMENT OF PTERIGIUM | 2023 |
|
RU2807900C1 |
| METHOD FOR DETERMINING DIFFERENTIATED TREATMENT INDICATIONS FOR EARLY HYPERTENSION PATIENTS AFTER HAVING ANTIGLAUCOMA OPERATIONS OF FILTERING TYPE | 2006 |
|
RU2308254C1 |
| CORNEA NEOVASCULARISATION AGGRESSIVE APPROACH | 2008 |
|
RU2369364C1 |
| METHOD TO TREAT NEOVASCULOGENESIS AS A RESULT OF THROUGH KERATOPLASTY | 2000 |
|
RU2183120C2 |
| METHOD OF TREATING 1 DEGREE PTERYGIUM | 2016 |
|
RU2613600C1 |
| METHOD OF SURGICAL TREATMENT OF RECURRENT PTERIGIUM | 2008 |
|
RU2354338C1 |
